SELAS PHARMACIE DU RAYOL CANADEL : revenue, balance sheet and financial ratios

SELAS PHARMACIE DU RAYOL CANADEL is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in RAYOL-CANADEL-SUR-MER (83820), this company of category PME shows in 2017 a revenue of 724 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE DU RAYOL CANADEL (SIREN 531652550)
Indicator 2023 2017 2016
Revenue N/C 723 719 € 745 012 €
Net income 87 003 € 65 143 € 54 295 €
EBITDA N/C 95 752 € 92 901 €
Net margin N/C 9.0% 7.3%

Revenue and income statement

In 2023, SELAS PHARMACIE DU RAYOL CANADEL generates positive net income of 87 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 54 k€ -> 87 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

87 003 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 33%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

32.943%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

59.704%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

25.3%

Solvency indicators evolution
SELAS PHARMACIE DU RAYOL CANADEL

Sector positioning

Debt ratio
32.94 2023
2016
2017
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -43 pts over 3 years

In 2023, the debt ratio of SELAS PHARMACIE DU RAYOL ... (32.94) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
59.7% 2023
2016
2017
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good +39 pts over 3 years

In 2023, the financial autonomy of SELAS PHARMACIE DU RAYOL ... (59.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
8.74 years 2017
2016
2017
Q1: 2.26 years
Med: 5.88 years
Q3: 10.41 years
Average +7 pts over 2 years

In 2017, the repayment capacity of SELAS PHARMACIE DU RAYOL ... (8.74) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 64.75. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

64.749

Liquidity indicators evolution
SELAS PHARMACIE DU RAYOL CANADEL

Sector positioning

Liquidity ratio
64.75 2023
2016
2017
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Watch -9 pts over 3 years

In 2023, the liquidity ratio of SELAS PHARMACIE DU RAYOL ... (64.75) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
16.23x 2017
2016
2017
Q1: 2.81x
Med: 8.18x
Q3: 15.34x
Excellent

In 2017, the interest coverage of SELAS PHARMACIE DU RAYOL ... (16.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS PHARMACIE DU RAYOL CANADEL

Positioning of SELAS PHARMACIE DU RAYOL CANADEL in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELAS PHARMACIE DU RAYOL CANADEL is estimated at 1 026 589 € (range 624 318€ - 1 443 154€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
624k€ 1026k€ 1443k€
1 026 589 € Range: 624 318€ - 1 443 154€
NAF 5 année 2023

Valuation method used

Net Income Multiple
87 003 € × 11.8x = 1 026 590 €
Range: 624 318€ - 1 443 155€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE DU RAYOL CANADEL with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE DU RAYOL CANADEL

What is the revenue of SELAS PHARMACIE DU RAYOL CANADEL ?

The revenue of SELAS PHARMACIE DU RAYOL CANADEL in 2017 is 724 k€.

Is SELAS PHARMACIE DU RAYOL CANADEL profitable?

Yes, SELAS PHARMACIE DU RAYOL CANADEL generated a net profit of 87 k€ in 2023.

Where is the headquarters of SELAS PHARMACIE DU RAYOL CANADEL ?

The headquarters of SELAS PHARMACIE DU RAYOL CANADEL is located in RAYOL-CANADEL-SUR-MER (83820), in the department Var.

Where to find the tax return of SELAS PHARMACIE DU RAYOL CANADEL ?

The tax return of SELAS PHARMACIE DU RAYOL CANADEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE DU RAYOL CANADEL operate?

SELAS PHARMACIE DU RAYOL CANADEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.